| miR-205 exerts a tumor-suppressive effect in human prostate by counteracting epithelial-to-mesenchymal transition and reducing cell migration/invasion, at least in part through the down-regulation of protein kinase Cepsilon. | prostate, |
| miRNA-205 is a glioma-specific tumor suppressor which targets VEGF-A. | glioma, |
| identified a series of differentially expressed miRNAs that could be useful as diagnostic or prognostic markers for melanoma and have shown that three miRNAs (namely miR-200c, miR-205 and miR-211) act as tumour suppressors | skin, |
| microRNAs that jointly act as tumor suppressors in prostate carcinoma | prostate, |
| Low levels of melanoma cell miR-205 expression as quantified by ISH show worse outcome, supporting the role of miR-205 as a tumor suppressor miRNA. | skin, |
| miR-205 is a tumor suppressor in human breast cancer by post-transcriptional inhibition of HER3 expression. | breast, |
| MiR-205 is a novel anti-oncogenic miRNA in KB oral cancer cells via down-regulation of Axin-2. | oral |
| miR-205 may play as a tumor suppressor in laryngeal squamous cell carcinoma, probably by targeting Bcl-2 | laryngeal, |
| miR-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma. | kidney, |
| Data showed that miR-205 was significantly reduced in prostate cancer (PCa) specimens, and restoration of the miRNA inhibited cancer cell migration and invasion, providing insights into the functional roles of miR-205 as a tumor suppressor in PCa cells. | prostate, |
| MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1) | colorectal, |
| miR-205 may function as a tumor suppressor via targeting TGF-alpha in Osteosarcoma | osteosarcoma, |
| miR-205 could serve as biomarker in esophageal cancer and acts as a tumor suppressor in esophageal adenocarcinoma and oncogene in esophageal squamous cell carcinoma. | esophageal, |
| miR-205 acts as a tumor suppressor in human osteosarcoma via directly targeting RUNX2. | osteosarcoma, |
| The results of the present study demonstrated that miR205, which has been reported to function as a tumor suppressor in various types of cancer, significantly suppressed the migration and invasion of gastric cancer cells, which may be correlated with its suppressive effects on epithelial-mesenchymal transition. | gastric, |
| our results supported that miR-205 was a miR specific to basal-like breast carcinoma (BLBC). which functioned as tumor suppressor gene through directly targeting and negatively regulating proto-oncogene KLF12. miR-205 dysregulation was involved in invasion and apoptosis. miR-205 and KLF12 provided a potential diagnosis biomarker and therapeutic approach for BLBC. | breast, |
| miR-205 resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine and acts as a tumor suppressor miRNA. | pancreatic, |
| microRNA?205 acts as a tumor suppressor and directly targets YAP1 in glioma | glioma, |
| Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol | breast, |
| miRNA?205?5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells | kidney, |